|Other Names||Probable E3 ubiquitin-protein ligase MID2, 632-, Midin-2, Midline defect 2, Midline-2, RING finger protein 60, Tripartite motif-containing protein 1, MID2, FXY2, RNF60, TRIM1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13639b was selected from the C-term region of MID2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Synonyms||FXY2, RNF60, TRIM1|
|Function||May play a role in microtubule stabilization.|
|Cellular Location||Cytoplasm. Cytoplasm, cytoskeleton. Note=Microtubule-associated|
|Tissue Location||Low level in fetal kidney and lung, and in adult prostate, ovary and small intestine|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is a member of thetripartite motif (TRIM) family. The TRIM motif includes threezinc-binding domains, a RING, a B-box type 1 and a B-box type 2,and a coiled-coil region. The protein localizes to microtubularstructures in the cytoplasm. Alternate splicing of this generesults in two transcript variants encoding different isoforms.
Lim, J., et al. Cell 125(4):801-814(2006)Jehee, F.S., et al. Am. J. Med. Genet. A 139(3):221-226(2005)Yap, M.W., et al. Proc. Natl. Acad. Sci. U.S.A. 101(29):10786-10791(2004)Short, K.M., et al. BMC Cell Biol. 3, 1 (2002) :Reymond, A., et al. EMBO J. 20(9):2140-2151(2001)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.